Genetic disruption of USP9X sensitizes colorectal cancer cells to 5-fluorouracil

被引:44
作者
Harris, Dennis R. [1 ]
Mims, Alexandra [2 ]
Bunz, Fred [1 ,2 ]
机构
[1] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21218 USA
[2] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Program Cellular & Mol Med, Baltimore, MD USA
关键词
USP9X; p53; chemotherapy; 5-fluorouracil; apoptosis; resistance; gene targeting; APOPTOSIS; P53; INSTABILITY; FAM/USP9X; SURVIVAL;
D O I
10.4161/cbt.21792
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The X-linked deubiquitinase USP9X affects the stability and activity of numerous regulatory proteins that influence cell survival. Recent studies suggest that decreased USP9X expression can confer a selective advantage onto developing cancer cells and thereby promotes disease progression. To examine the effect of USP9X on the cellular responses to anticancer therapies, we derived cancer cell lines in which the USP9X locus was disrupted by homologous recombination. The resulting USP9X-deficient cancer cells exhibited increased activation of apoptotic pathways and markedly decreased clonogenic survival in response to 5-fluorouracil, a chemotherapeutic drug that is widely used for treatment of gastrointestinal malignancies. These unexpected results suggest that cancers with low USP9X expression might be specifically sensitized to some conventional therapeutic agents.
引用
收藏
页码:1319 / 1324
页数:6
相关论文
共 22 条
[1]   The HECT family of E3 ubiquitin ligases: Multiple players in cancer development [J].
Bernassola, Francesca ;
Karin, Michael ;
Ciechanover, Aaron ;
Melino, Gerry .
CANCER CELL, 2008, 14 (01) :10-21
[2]   Disruption of p53 in human cancer cells alters the responses to therapeutic agents [J].
Bunz, F ;
Hwang, PM ;
Torrance, C ;
Waldman, T ;
Zhang, YG ;
Dillehay, L ;
Williams, J ;
Lengauer, C ;
Kinzler, KW ;
Vogelstein, B .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (03) :263-269
[3]   FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer [J].
Conroy, Thierry ;
Desseigne, Francoise ;
Ychou, Marc ;
Bouche, Olivier ;
Guimbaud, Rosine ;
Becouarn, Yves ;
Adenis, Antoine ;
Raoul, Jean-Luc ;
Gourgou-Bourgade, Sophie ;
de la Fouchardiere, Christelle ;
Bennouna, Jaafar ;
Bachet, Jean-Baptiste ;
Khemissa-Akouz, Faiza ;
Pere-Verge, Denis ;
Delbaldo, Catherine ;
Assenat, Eric ;
Chauffert, Bruno ;
Michel, Pierre ;
Montoto-Grillot, Christine ;
Ducreux, Michel .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (19) :1817-1825
[4]   FAM/USP9x, a Deubiquitinating Enzyme Essential for TGFβ Signaling, Controls Smad4 Monoubiquitination [J].
Dupont, Sirio ;
Mamidi, Anant ;
Cordenonsi, Michelangelo ;
Montagner, Marco ;
Zacchigna, Luca ;
Adorno, Maddalena ;
Martello, Graziano ;
Stinchfield, Michael J. ;
Soligo, Sandra ;
Morsut, Leonardo ;
Inui, Masafumi ;
Moro, Stefano ;
Modena, Nicola ;
Argenton, Francesco ;
Newfeld, Stuart J. ;
Piccolo, Stefano .
CELL, 2009, 136 (01) :123-135
[5]   Zymophagy, a Novel Selective Autophagy Pathway Mediated by VMP1-USP9x-p62, Prevents Pancreatic Cell Death [J].
Grasso, Daniel ;
Ropolo, Alejandro ;
Lo Re, Andrea ;
Boggio, Veronica ;
Molejon, Maria I. ;
Iovanna, Juan L. ;
Gonzalez, Claudio D. ;
Urrutia, Raul ;
Vaccaro, Maria I. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (10) :8308-8324
[6]   DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 [J].
Hahn, SA ;
Schutte, M ;
Hoque, ATMS ;
Moskaluk, CA ;
daCosta, LT ;
Rozenblum, E ;
Weinstein, CL ;
Fischer, A ;
Yeo, CJ ;
Hruban, RH ;
Kern, SE .
SCIENCE, 1996, 271 (5247) :350-353
[7]   Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells [J].
Hwang, PM ;
Bunz, F ;
Yu, J ;
Rago, C ;
Chan, TA ;
Murphy, MP ;
Kelso, GF ;
Smith, RAJ ;
Kinzler, KW ;
Vogelstein, B .
NATURE MEDICINE, 2001, 7 (10) :1111-1117
[8]   p21 gene knock down does not identify genetic effectors seen with gene knock out [J].
Karakas, Bedri ;
Weeraratna, Ashani T. ;
Abukhdeir, Abde M. ;
Konishi, Hiroyuki ;
Gustin, John P. ;
Vitolo, Michele I. ;
Bachman, Kurtis E. ;
Park, Ben Ho .
CANCER BIOLOGY & THERAPY, 2007, 6 (07) :1025-1030
[9]  
Kim JS, 2002, MOL CANCER THER, V1, P1355
[10]   Genetic instability in colorectal cancers [J].
Lengauer, C ;
Kinzler, KW ;
Vogelstein, B .
NATURE, 1997, 386 (6625) :623-627